Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 6, 1998, Pages 612-613

  Prins, Jan M ^a,b   Schellekens, Peter Th A ^a   Reiss, Peter ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LAMIVUDINE; PREDNISONE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ADULT; ARTICLE; CASE REPORT; ERYTHEMA; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPS; HYPERSENSITIVITY REACTION; NAUSEA; NONHUMAN; RASH; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DRUG HYPERSENSITIVITY; FEMALE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MIDDLE AGED; PREDNISONE;

EID: 0032457178     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Rietsema WJ. Fever, erythroderma, abdominal pain, and renal failure following initiation of indinavir therapy. Clin Infect Dis 1997; 25: 1268-9.
2. Bonfanti P, Capetti A, Riva P, Testa L, Quirino T. Hypersensitivity reactions during antiretroviral regimens with protease inhibitors. AIDS 1997; 11: 1301-2.
3. Lipsky BA, Hirschmann JV. Drug fever. JAMA 1981; 245: 851-854.
4. Carayannopoulos L, Capra JD. Immunoglobulins. In: Paul WE, editor, Fundamental Immunology. 3rd ed. New York: Raven Press, 1993, p. 283-314.